Cellife 4-in-1 COVID-19, RSV & Flu A/B Rapid Antigen Test

Rapidly Test for Four Common Respiratory Viruses

The Cellife SARS-CoV-2, RSV and Influenza A/B Antigen Combo Rapid Test Kit (LFIA) is a one-step in vitro diagnostic test designed to detect four common respiratory viruses using a single anterior nasal swab.

The test provides a rapid qualitative result for:

• SARS-CoV-2 nucleocapsid antigen
• Respiratory Syncytial Virus (RSV) antigen
• Influenza A nucleocapsid antigen
• Influenza B nucleocapsid antigen

Intended Use

This test is intended for self-testing by individuals aged 18 years and over who are experiencing symptoms associated with COVID-19, RSV, Influenza A or Influenza B. It is designed for use within the first four days after symptoms begin.

Individuals under 18 years of age should only use the test with assistance from an adult.

Instructions for Use

Read the complete Instructions for Use before performing the test.

View Instructions for Use

Important Information

This test provides preliminary results and should not be used as the sole basis for diagnosing or excluding SARS-CoV-2, RSV, Influenza A or Influenza B infection.

Negative results do not completely rule out infection. Follow the Instructions for Use carefully and seek medical advice when appropriate.

Reporting performance or usability issues
To report a medical device incident, call 1800 809 361 or email iris@health.gov.au.